Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies […]
Agreement grants JH Health exclusive rights to use and distribute Atelerix’s portfolio of non-cryogenic preservation solutions in the region Expands
Last month, Atelerix hosted its first-ever customer showcase event at Hauxton House, bringing together partners and collaborators to share how
This week, Atelerix teamed up with Cherry Biotech to explore a simple but powerful question: What if organoids could be
Earlier this month, the Atelerix team had the pleasure of attending WORD+2026, the 4th Annual World Organoid and Organ-on-a-Chip Research
Partnership brings together proven non-cryogenic biosample preservation technology and advanced organoid models to support growth in preclinical research and biotech
Agreement to broaden access, streamline logistics, and reduce variability associated with temperature-sensitive shipping of 3D tissue models, without cryopreservation Joint
The Atelerix team were delighted to take part in ELRIG Drug Discovery 2025, held at the ACC in Liverpool on
Agreement with specialist life science and diagnostic labs distributor expands global operational reach and market penetration New distribution channels to
Initial agreement to incorporate Atelerix’s non-cryogenic cell preservation technology into international freight and logistics services for drug discovery and clinical
Abstract Contract Research Organisations (CROs) are increasingly adopting organoid models for drug discovery, toxicology, and preclinical testing. These three-dimensional cellular
By Sophie Reay Organoids are three-dimensional (3D) tissue cultures derived from stem cells that self-organise into structures that closely
